Rehabilitation in Amyotrophic Lateral Sclerosis: literature review
DOI:
https://doi.org/10.11606/issn.2317-0190.v15i3a102947Keywords:
Amyotrophic Lateral Sclerosis, Rehabilitation, Review Literature as TopicAbstract
Amyotrophic Lateral Sclerosis is a motor neuron pathology that results in a high degree of impairment. There is a worldwide tendency to create standardization manuals regarding the approach of this population, mainly on the subject of rehabilitation and quality of life. We conducted a review of the published guidelines related to this issue in a strict, non-systematic way and based on this published material, created a proposal for an up-to-date, comprehensive and simple manual adapted to the Brazilian reality.
Downloads
References
Dubrovsky AL, Sica RE. Current treatment pathways in ALS: a South American perspective. Neurology. 1999;53(8 Suppl 5):S11-6.
Cronin S, Hardiman O, Traynor BJ.Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68(13):1002-7.
Bradley WG, Anderson F, Bromberg M, Gutmann L, Harati Y, Ross M, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology. 2001;57(3):500-4.
Bertorini TE, editor. Clinical evaluation and diagnostic tests for neuromuscular disorders. Woburn: Butterworth-Heinemann; 2002.
Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66(2):265-7.
Kaufmann P, Levy G, Thompson JL, Delbene ML, Battista V, Gordon PH, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology. 2005;64(1):38-43.
Xerez DR, Rocha PGO, Aguiar CA, Saadi LMV. Profile of the population yhat underwent chemical neurolysis with botulim toxin type A in a Brasilian PM&R Universitary center between 2002-2007 [p441]. J Rehabil Med. 2008;40(Suppl 47):271-2. [Presented at 16th European Congress of Physical Medicine and Rehabilitation Medicine; 2008; Brugge, Belgium.
Smithson WH.Integrating the algorithm into community practice. Neurology. 1999;53(8 Suppl 5):S63-6.
Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff MM, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65(8):1264-7.
Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311-23.
Bryson HM, Fulton B, Benfield P. Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs. 1996;52(4):549-63.
Hyson H, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord. 2002;17(6):1318-20.
Verma A, Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve. 2006;34(2):235-7.
Newall AR, Orser R, Hunt M. The control of oral secretions in bulbar ALS/MND. J Neurol Sci. 1996;139 Suppl:43-4.
Gallagher JP. Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand. 1989;80(2):114-7.
Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004;63(8):1364-70.
Diener HC, Dethlefsen U, Dethlefsen-Gruber S, Verbeek P. Effectiveness of quinine in treating muscle cramps: a double-blind, placebo-controlled, parallel-group, multicentre trial. Int J Clin Pract. 2002;56(4):243-6.
Borasio GD, Voltz R, Miller RG. Palliative care in amyotrophic lateral sclerosis. Neurol Clin. 2001;19(4):829-47.
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
